ENBREL FDA APPROVED FOR EXPANDED INDICATION

October 1, 2003

The FDA approved Amgen and Wyeth Pharmaceuticals drug, Enbrel (etanercept), to inhibit the progression of structural damage in patients with active psoriatic arthritis and reduce its signs and symptoms.